Member Info for justdeezerts

Itaconix (AIM:ITX)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Itaconix plc, with a market cap of £19.55 million, develops plant-based polymers for home and personal care applications in North America and Europe.

Operations: The company generates revenue from two main segments: Formulation Solutions, contributing $1.51 million, and Performance Ingredients, accounting for $5.10 million.

Market Cap: £19.55M

Itaconix plc, with a market cap of £19.55 million, focuses on plant-based polymers and has faced challenges with declining sales, reporting US$2.78 million for the first half of 2024 compared to US$4.03 million the previous year. Despite being unprofitable and having a negative return on equity (-18.4%), Itaconix is debt-free and maintains sufficient cash runway for over a year based on current free cash flow trends. The company is leveraging its seasoned management team to drive innovation through initiatives like the SPARX program, aiming to introduce new sustainable products in collaboration with industry partners by 2025.

Take a closer look at Itaconix's potential here in our financial health report.

Gain insights into Itaconix's outlook and expected performance with our report on the company's earnings estimates.

Halls - It is of little consequence if revenues, margins and cash are down. Just focus is what happened with bottom-line profitability and H1 was a marked improvement on the previous 6 months. Bank facility remains in place for another 2 years and for that to happen, the company's bankers would have had to satisfy themselves on TLY's future prospects .

So get a grip and move on....

On cash flow statement, we seem to have paid out 567k in H1. That followed a previous payment of £1.013m in H2 of 2023/24. Does anyone know what asset we’re talking about here and are there any further instalments to be paid out? Sounds like a strain on cash to me

DYOR

Spread.... typo, sorry.

120p-137p??

If you want to buy today, the MMs are telling you not to bother...... They were happy to take out a few panic sales @ 95p... That's AIM for you.

At least we know what will happen when we get the next positive TU.

All LTHs have a great weekend.

Agreed Wilcat - it’s just a shame that the brokers don’t see it as an opportunity to place these shares with their institutional clients at this giveaway price. That’s their role, I think…

You’ve got to hand it to JS.

At close of business on 9 September (the evening before the half year results were announced), the SP closed @ 168.50p. Following the next morning’s RNS and a subsequent investor presentation, he has managed to get the SP down to 100p. Perhaps he’ll come up with a plan to reverse the spiral in the next six weeks.

Not even the company’s brokers give a damn.

Says it all!! DYOR

AJ: There's a well known phrase in the betting world: "Just follow the money".

Unfortunately, Trump is ahead in all of the latest reputable betting websites. Apparently, the betting odds have only been wrong on two occasions since 1866 - in 2016 (Clinton) & 1948 (Dewey).

As you say, let's hope this is going the third time for all our sakes...

So hold on to your hats with fingers x'd.

DYOR

JS has no respect for PIs in his company. As I have said before, he runs ITX like a personal fiefdom with little understanding on how to keep shareholders informed. And when he does deign to give a presentation, it is often an unconvincing, stumbling, unprofessional performance. MMs will drive down this SP at will, until some of the many (frustrated) institutional holders wake up and say to him: " John, enough is enough!"

DYOR

Https://simplywall.st/stocks/gb/healthcare/aim-tly/totally-shares

DYOR

Thanks Halls - you’re a laugh with afternoon tea, too!

i've come to the conclusion that 'halls' is an ai bot.

anyway, thanks for a very amusing read with an early morning coffee and a ***.

your daily quips (well, they can't really be considered as serious, can they?) come as a welcome relief in this crazy world we live in.

keep it going, halls...

WildCat - yes I agree. As an FD, I've seen it all before. An inventor of a listed company convinced that it's his baby and no-one can look after it other than him. If that continues, ITX will end up as a not-for-profit development company.

Getting JS to let go of the reins will be the biggest problem. Until he does, he will do what every other inventor does - carry on spend money with improved prototypes, until someone else comes along with a competing product and beats ITX to the commercial market.

We live in hope!

AJP - you got it in one! Awful presentation - John's reluctant sheepish admission that the EBITDA loss for the year will increase said it all, I'm afraid.

Company with great potential, but the phrase 'net PROFIT' not mentioned even once.

Laura needs to prepare herself much better to read out investors' questions - not impressed.

Even the presentation was only chart-based with John literally reading out what was being displayed. Nothing new to keep investors interested.

V. disappointing and there is little likelihood of any more news until the next trading update.

What do MSK physiotherapists do?

They assess and treat people who have any injury, disease or problem that relates to muscles, bones, joints and peripheral nerves. They may also provide advice to help you manage your condition, or refer you to other services as appropriate.

Another string to the bow - onwards and upwards.

DYOR

Https://www.bbc.co.uk/sounds/play/p0jlrvnc

Hi bumble! Yep, 2Good always starts my morning with a good laugh.

He has clearly invested in NANO, where the SP decreased by 30 per cent in the month July. Also, there have been 11m shares purchased there since April - however nearly half of them were by the company itself buying them back. I suppose that's one way of preventing the SP going even lower.

Whilst this isn't really the BB for my question, but perhaps we can get an explanation from 2Good for this strange 'buying-in' strategy? Just enquiring!

DYOR

Hallsworthy - you really need to read past results. Margins have commuted between 16% and 18.5% since 2019.

In 2019, revenue was £105.9 on margins of 18.1%. with EBITDA of £4m.

2024 results show revenue £106.7m, margins 16.6% and EBITDA £2.3m.

Projected 2025: revenue £85m EBITDA £3.5m.

It never been about margins, it's all about adapting costs to fit the business in hand.

That why the SP has gone from 4p to 10p in under 4 months.

Shrewd investors understand this - why can't you? Just asking.

DYOR

IWant... Agree with your comments on the latest RNS.

You're correct in that EBITDA reflects the cash movement - Dartron has got this wrong 'totally' (excuse the pun)

No sane CEO is going to explain its strategy to improve margins on a BB - wishful thinking, or simply attempting to trash a share for the sake of it!

TLY is but a small cog in this giant NHS behemoth.

Plenty of business to go round and as long as TLY keeps its place as no.1 or no.2 in its specific niche market, why would its client bother change providers?

There are so many more urgent issues to deal with?

DYOR

Welcome back 2good, Sage of Bad Investments.

You just carry on throwing good money into SYME - that's one of your recommendations, isn't it?

You've been trashing TLY since they were 4p - painful missing out, as they improved by 150 per cent in last couple of months - even NVIDIA couldn't claim that increase!.

But TANKS for the reminder, anyway - ha, ha!